1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

Animal Antibiotics and Antimicrobials Market: Global Forecast until 2021

  • December 2016
  • 210 pages
  • ID: 4489948
In this report:
This is mainly attributed to the rising demand for livestock products in developing countries such as India and Russia, where milk and meat consumption has increased by ##% and ##% between 2010 and 2014, respectively.
Spain exports ##,##,## tons of pork annually, which is ##% of the total production of pork in the country.

Summary

Table of Contents

Search Inside

The overall animal antibiotics and antimicrobials market is forecasted to grow at a compound annual growth rate (CAGR) of 4.60 percent from 2016 to 2021, to attain ~$4.7B by 2021 from ~$3.8B in 2016. The rise of this market is essentially attributed to growing demand for animal-derived food products, increasing demand for pet insurance and increasing animal health expenditure, and growing incidences of zoonotic diseases. Additionally, the implementation of the regulations for preventing the spread of animal diseases and rising awareness about animal healthcare are further anticipated to drive the increase of this market. On the other hand, increasing resistance to the antibiotic and antimicrobial agents, dearth of new antibiotics, and replacement of routine prophylactic use of antibiotics by good husbandry and hygiene practices may hinder the rise of this market to certain extent. Untapped emerging market including China, India (IN) affords significant increase opportunities.

Established on the type of product, the animal antibiotics and antimicrobials market is broken down into tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins, and other antimicrobials and antibiotics. On the basis of mode of delivery, the sector is further split into premixes, oral powders, oral solutions, injections, and other modes of delivery. Equivalently, on the basis of class of animals the animal antibiotics and antimicrobials market is divided into food-producing animals and companion animals. The food-producing animals segment recorded for the biggest share of the animal antibiotics and antimicrobials market in 2015.

Geographically, the overall animal antibiotics and antimicrobials market is divided into north america, Europe (EU), Asia-Pac, and the Rest of the globe. In 2015, North America continent commanded a main share of the animal antibiotics and antimicrobials market. This is primarily due to the growing adoption of companion animals, increasing pet insurance sector, growing demand for animal-derived food products, and increasing veterinary healthcare expenditure in the territory.

Nevertheless, Asia Pacific (APAC) is anticipated to witness the more important increase rate during the outlook period. Increase in the APAC market can be accredited to increasing companion animal population and rise in the industry demand for animal-derived food products.

Some of the prominent actors in the animal antibiotics and antimicrobials market contain Zoetis, Incorporated, Eli Lilly and Organization, Merck & Co., Incorporated, Bayer (ETR:BAYN), Boehringer Ingelheim GmbH, Virbac, Ceva Sante Animale, Vetoquinol S.A., and Dechra Pharmaceuticals PLC

Segment Research

Moreover to deep down segmentation provided in this business report, it briefs about the market dynamics including drivers, market restraints, alternatives, opportunities, and market trends. The market research also includes the regulatory review for the production and marketing of the animal antibiotic and antimicrobial products. Additionally, this industry report highlights the increase strategies approved by the main market players to collect larger share in the animal antibiotics and antimicrobials market.

Why Purchasing This Study Can Help You:

The industry report will increase both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate organizations in garnering a greater market share. Companies obtaining the study could use any one or combination of the below-mentioned five strategies (sector entry, product improvement/innovative projects, sector development, business diversification, and opposing assessment) for growing their market shares.

This study furnishes highlights on the following points:

- Business entry: Exhaustive information on the product types provided by the top actors in the animal antibiotics and antimicrobials market. The market research examines the animal antibiotic and antimicrobial agents market by product, mode of delivery, animal type, and area

- Product improvement/Innovative products: In-depth understanding on the next trends, analysis and growth activities, and recent product launches in the animal antibiotics and antimicrobials market

- Industry development: Highlighted information about profitable emerging sectors by product and area

- Industry diversification: Complete information about recent products, increasing geographies, recent evolutions, and market investments in the animal antibiotics and antimicrobials market

- Opposing assessment: Detailed assessment of market shares, increase strategies, products, and manufacturing competences of key players in the animal antibiotics and antimicrobials market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Acne Vulgaris Global Clinical Trials Review, H2, 2018

Acne Vulgaris Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018

Acne Vulgaris Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2018" provides an overview of Acne Vulgaris clinical ...

Alcohol Addiction Global Clinical Trials Review, H2, 2018

Alcohol Addiction Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018

Alcohol Addiction Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H2, 2018" provides an overview of Alcohol Addiction ...

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2018

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2018SummaryAccording ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on